Time to reperfusion in acute myocardial infarction. It is time to reduce it!

被引:21
作者
Barbagelata, Alejandro
Perna, Eduardo R.
Clemmensen, Peter
Uretsky, Barry F.
Canella, Juan P. Cimbaro
Califf, Robert M.
Granger, Christopher B.
Adams, George L.
Merla, Ramanna
Birnbaum, Yochai
机构
[1] Univ Texas, Med Branch, Galveston, TX 77555 USA
[2] Inst Cardiol JF Cabral, Corrientes, Argentina
[3] Rigshosp, DK-2100 Copenhagen, Denmark
[4] Duke Univ, Clin Res Inst, Durham, NC USA
关键词
D O I
10.1016/j.jelectrocard.2007.01.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Objectives: Mortality from ST-segment elevation myocardial infarction remains high, with most deaths occurring before hospital admission. Despite effective pre- and in-hospital reperfusion strategies becoming standard over the past 2 decades, time-to-admission and time-to-treatment remain prolonged. We reviewed temporal trends in these times in published clinical trials. Methods: All major randomized clinical trials reporting on reperfusion strategies for acute myocardial infarction published between 1993 and 2003 were evaluated. Strategies included pre- and in-hospital thrombolysis, primary percutaneous coronary intervention (pPCI) with or without transfer, and "facilitated' PCI. We generated overall estimates of time-to-admission, time-to-treatment, door-to-balloon (DTB), and door-to-needle (DTN) times and evaluated temporal trends in the length of time-to-admission and time-to-treatment. Results: In studies that evaluated only in-hospital thrombolysis, the time-to-admission was 149 +/- 45 minutes; the mean time-to-treatment was 181 +/- 29 minutes. In studies that considered only in-hospital pPCI (without transfer), the mean time-to-admission was 153 +/- 41 minutes; the mean time-to-treatment was 234 43 minutes. In studies that compared in-hospital pPCI with in-hospital thrombolytic therapy, the mean time-to-admission was 155 +/- 47 and 150 48 minutes, respectively. The DTN time was 65 10 minutes, whereas DTB time was 81 +/- 3 9 minutes. In other trials evaluating in-hospital thrombolysis and pPC1 with transfer to a referral center, the time-to-admission in subjects treated with thrombolysis (n 1345) was 127 +/- 32 minutes vs 131 +/- 36 minutes for pPCI (n = 1528). For in-hospital thrombolysis, time-to-treatment was 151 +/- 23 minutes vs 203 +/- 15 minutes for pPCI patients with transfer. The DTN time in the thrombolysis group was 44 28 minutes as compared with DTB time of 78 +/- 38 minutes in the pPCI group. Throughout the last decade, time-to-admission decreased significantly (P = .02) but time-to-treatment remained unchanged (P =.38) for patients undergoing thrombolysis. In the pPCI arm, time-to-admission remained unchanged (P = .11) but a insignificant trend toward reduction was demonstrated in time-to-treatment (P = .11). Conclusion: Time-to-admission and time-to-treatment for ST-segment: elevation myocardial infarction are still prolonged. Resources should be directed to early recognition of the acute myocardial infarction, improved utilization of emergency services for transportation, and prehospital diagnosis and triaging. Ambulances equipped with wireless capability to transmit electrocardiograms to the on-call cardiologist seem to be promising tools to achieve earlier diagnosis and triaging with high diagnostic sensitivity and specificity. (C) 2007 Published by Elsevier Inc.
引用
收藏
页码:257 / 264
页数:8
相关论文
共 70 条
  • [1] ANDERSEN H, 2002, AM COLL CARD 51 ANN
  • [2] Predictors of door-to-balloon delay in primary angioplasty
    Angeja, BG
    Gibson, CM
    Chin, R
    Frederick, PD
    Every, NR
    Ross, AM
    Stone, GW
    Barron, HV
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2002, 89 (10) : 1156 - 1161
  • [3] [Anonymous], 1986, Lancet, V1, P397
  • [4] [Anonymous], 1994, LANCET, V343, P311
  • [5] Antman Elliott M, 2004, J Am Coll Cardiol, V44, P671, DOI 10.1016/j.jacc.2004.07.002
  • [6] Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction - Results of the ENTIRE-thrombolysis in myocardial infarction (TIMI) 23 trial
    Antman, EM
    Louwerenburg, HW
    Baars, HF
    Wesdorp, JCL
    Hamer, B
    Bassand, JP
    Bigonzi, F
    Pisapia, G
    Gibson, CM
    Heidbuchel, H
    Braunwald, E
    Van de Werf, F
    [J]. CIRCULATION, 2002, 105 (14) : 1642 - 1649
  • [7] Relation of time to treatment and mortality in patients with acute myocardial infarction undergoing primary coronary angioplasty
    Antoniucci, D
    Valenti, R
    Migliorini, A
    Moschi, G
    Trapani, M
    Buonamici, P
    Cerisano, G
    Bolognese, L
    Santoro, GM
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2002, 89 (11) : 1248 - 1252
  • [8] Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery - A randomized controlled trial
    Aversano, T
    Aversano, LT
    Passamani, E
    Knatterud, GL
    Terrin, ML
    Williams, DO
    Forman, SA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (15): : 1943 - 1951
  • [9] Bar FW, 1997, AM J CARDIOL, V79, P727
  • [10] Denying reperfusion or falsely declaring emergency: the dilemma posed by ST-segment elevation
    Barbagelata, Alejandro
    Ware, David L.
    [J]. JOURNAL OF ELECTROCARDIOLOGY, 2006, 39 (04) : S73 - S74